AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,038,000 | -65.8% | 200,808 | -83.0% | 0.02% | -65.2% |
| Q2 2022 | $8,878,000 | -10.6% | 1,183,676 | +8.5% | 0.07% | +3.0% |
| Q1 2022 | $9,931,000 | +39.4% | 1,091,297 | +7.6% | 0.07% | +39.6% |
| Q4 2021 | $7,122,000 | +3.3% | 1,014,556 | +67.8% | 0.05% | +4.3% |
| Q3 2021 | $6,893,000 | -25.5% | 604,639 | +4.6% | 0.05% | -27.0% |
| Q2 2021 | $9,251,000 | +158.6% | 577,832 | +188.6% | 0.06% | +125.0% |
| Q1 2021 | $3,578,000 | -51.2% | 200,228 | -63.1% | 0.03% | -56.2% |
| Q4 2020 | $7,325,000 | +312.7% | 542,175 | +259.6% | 0.06% | +255.6% |
| Q3 2020 | $1,775,000 | – | 150,790 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 244,783 | $1,718,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $32,959,000 | 0.69% |
| DCF Advisers, LLC | 192,065 | $1,348,000 | 0.55% |
| LEVIN CAPITAL STRATEGIES, L.P. | 817,377 | $5,738,000 | 0.54% |
| DAFNA Capital Management LLC | 289,040 | $2,029,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 750,000 | $5,378,000 | 0.36% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,175,000 | 0.31% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,203,592 | $8,449,000 | 0.30% |
| AlphaCentric Advisors LLC | 137,000 | $962,000 | 0.28% |
| PFM Health Sciences, LP | 1,088,566 | $7,642,000 | 0.26% |